C. Ola Landgren

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

C. Ola Landgren
May 24, 2025, 18:06 | Insight
New Standard of Care Emerges for Multiple Myeloma
ADVANCE Clinical Trial Suggests That New Four-Drug Combination is Highly Effective and Safe in Newly…
May 19, 2025, 10:14 | Blog
Karina Herrera Schoene: The CAR-T Cell Immersion at the University of Miami
Karina Herrera Schoene, Senior Hematology Product Manager at The Janssen Pharmaceutical Companies of Johnson & Johnson,…
May 19, 2025, 01:08 | Blog
C. Ola Landgren: The 2nd Annual “Advancing Precision Medicine: Frontiers in MM Management” has been a huge success
C. Ola Landgren, Leader, Translational and Clinical Oncology Program/Experimental Therapeutics at Sylvester Comprehensive Cancer Center,…
Apr 22, 2025, 14:35 | Blog
C. Ola Landgren Expands Myeloma Program at Sylvester Comprehensive Cancer Center
C. Ola Landgren, Leader, Translational and Clinical Oncology Program/Experimental Therapeutics at Sylvester Comprehensive Cancer Center,…
Apr 20, 2025, 11:51 | Blog
C. Ola Landgren: The 11th Annual Miami Myeloma MRD Meeting was a huge success!
C. Ola Landgren, Professor of Medicine, Chief of the Division of Myeloma at University of…
Mar 12, 2025, 17:09 | Blog
Deborah Pulido: A hybrid event at Sylvester Comprehensive Cancer Center with LLS
Deborah Pulido, Patient and Community Outreach Manager at the Leukemia and Lymphoma Society, shared a…
Mar 4, 2025, 09:07 | Blog
C. Ola Landgren: Thrilled to welcome Brian Walker to the Sylvester Myeloma Institute
Ola Landgren, Professor of Medicine, Chief of the Division of Myeloma at University of Miami…
Feb 27, 2025, 17:49 | Blog
C. Ola Landgren: Register now for the annual Miami Myeloma MRD Meeting
C. Ola Landgren, Professor of Medicine, Chief of the Division of Myeloma at University of…
Dec 10, 2024, 10:40 | Insight
Highlights from ASH24 Day 2
The 66th ASH Annual Meeting and Exposition, is being held from December 7-10, 2024, in…
Dec 9, 2024, 18:26 | Blog
C. Ola Landgren: 20 years of collaboration and friendship
Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader of…
Nov 25, 2024, 14:11 | Blog
Sylvester Cancer Oral Presentations at ASH 2024
Researchers from Sylvester Comprehensive Cancer Center and the Miller School of Medicine at the University…
Oct 31, 2024, 17:06 | Blog
Sarah Louden: The latest insights and breakthroughs from the ESMO USA East meeting
Sarah Louden, Founder and CEO at Total Health Oncology, shared on LinkedIn: ''ESMO USA East…
Aug 2, 2024, 23:39 | Blog
The efficacy of BMA and the role of precision medicine in Myeloma
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader…
Jul 28, 2024, 07:55 | Blog
Luciano J Costa: MRD accelerating myeloma drug development
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Luciano J Costa, Professor of…
Jul 27, 2024, 10:13 | Insight
Luciano J Costa: MRD accelerating myeloma drug development
Luciano J Costa, Professor of Medicine at the University of Alabama Medicine, shared on X: "MRD…
Jul 25, 2024, 14:07 | Insight
Learn how Carl Ola Landgren is creating a risk profile to personalize myeloma care - HealthTree Foundation
HealthTree Foundation shared on X: "Learn how Dr. C. Ola Landgren and his colleagues at…
Jul 24, 2024, 22:05 | Blog
'FLAGSHIP' study opened at Sylvester Comprehensive Cancer Center's Myeloma Institute
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader…
Jul 4, 2024, 03:09 | Blog
C. Ola Landgren: Highlights in Multiple Myeloma From ASCO and EHA 2024
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader…
Jun 22, 2024, 04:41 | Insight
C. Ola Landgren: How Quadruplet Therapy Is Changing the Myeloma Treatment Landscape
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader…
Jun 4, 2024, 16:31 | Societies
Just presented at ASCO24: IMROZ results by C. Ola Landgren - ASCO
ASCO shared a post on X: “Just presented at American Society of Clinical Oncology 2024…
May 26, 2024, 14:20 | Blog
C. Ola Landgren on Quadruple Therapies and the Future of Multiple Myeloma Treatment
Sylvester researcher C. Ola Landgren will present an overview of new studies and the state…
May 24, 2024, 01:21 | Insight
Recent FDA Committee Vote Could Speed Multiple Myeloma Drug Approval
Sylvester-led analysis on minimal residual disease as clinical endpoint guided committee decision A U.S. Food…
May 10, 2024, 10:58 | Blog
Francesco Maura: How Vk*MYC Mouse genomic evolution mimics the one observed in human myeloma
Francesco Maura, Assistant Professor at Sylvester Comprehensive Cancer Center, shared a post on X: "New paper…
May 7, 2024, 15:56 | Blog
Sylvester Comprehensive Cancer Center - Firefighter Cancer Initiative and David Perez' story
Sylvester Comprehensive Cancer Center shares a story of a firefighter diagnosed with multiple myeloma discussing…
Apr 27, 2024, 07:10 | Insight,Opinion
Benjamin Diamond: Our paper on genomic profiling of high-risk smouldering myeloma now in Clinical Cancer Research
Benjamin Diamond, Assistant Professor of the Myeloma Institute at the Sylvester Comprehensive Cancer Center, shared…
Apr 25, 2024, 21:33 | Blog
C. Ola Landgren: It was an honor to present the EVIDENCE meta-analysis at ODAC
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader…
Mar 13, 2024, 16:38 | Blog
C. Ola Landgren: An ADVANCED MYELOMA FELLOWSHIP position at University of Miami, Sylvester Comprehensive Cancer Center in Miami!
C. Ola Landgren, Leader of Experimental Therapeutics at Sylvester Comprehensive Cancer Center, on LinkedIn: “NEW…
Nov 6, 2023, 03:22 | Blog
C. Ola Landgren: The launching of a new computational oncology fellowship/post-doc opportunity
Quoting C. Ola Landgren, Leader of Experimental Therapeutics at Sylvester Comprehensive Cancer Center, on LinkedIn:…
All: 28 Posts: 1 - 100
Special Coverage